Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Cancer Causes Control. 2014 May 16;25(7):905–913. doi: 10.1007/s10552-014-0390-6

Table 4.

Evaluation of effect heterogeneity among selected maternal and birth characteristics and childhood rhabdomyosarcoma histologic subtypes

Characteristic Embryonal RMS
n=215
Alveolar RMS
n=66

ORa 95% CI ORa 95% CI p for heterogeneity

Ever used any birth control 1.19 0.80–1.79 1.41 0.75–2.62 0.624
Using birth control when became pregnant 1.51 0.59–3.90 1.13 0.23–5.40 0.706
Spotting/cramping/abnormal vaginal bleeding 1.80 1.10–2.92 2.49 1.25–5.00 0.357
Anemia during pregnancy 1.17 0.72–1.88 1.26 0.61–2.62 0.842
Type of delivery
 Vaginal 1.00 Reference 1.00 Reference
 Cesarean 1.60 1.00–2.56 1.18 0.53–2.63 0.449
Birth weightb
 Normal (2,500g to <4,000g) 1.00 Reference 1.00 Reference
 LBW (<2,500g) 1.64 0.62–4.32 4.46 1.41–14.1
 HBW (≥4,000g) 1.61 0.93–2.79 2.41 1.09–5.35 0.169
Length of pregnancyc
 Normal 1.00 Reference 1.00 Reference
 Premature 2.47 0.93–6.59 0.95 0.23–4.00
 Overdue 0.58 0.33–1.02 0.95 0.44–2.08 0.155

RMS = rhabdomyosarcoma; OR = odds ratio; CI = confidence interval; LBW = low birth weight; HBW = high birth weight

a

Adjusted for sex, age, and race.

b

Adjusted for length of pregnancy.

c

Adjusted for birth weight.